Malignant Digestive System Neoplasm — Trials

Malignant Digestive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

19,110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,263
Recruiting: 2,366
Ph III recruiting: 290
Growth YoY: +12.2%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 28.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2,003)

clinicaltrialsPublishedShowing 551–600 of 3,117 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05592626	A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors(START-001)	recruiting	Phase 1 / Phase 2	366	Marengo Therapeutics, Inc.INDUSTRY	4	Aug 11, 2026	clinicaltrials
NCT05706129	A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors	recruiting	Phase 1 / Phase 2	270	Lumara Bio Oncologics GmbH